Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Possibilities of antihypertensive therapy in correction of cognitive impairment in hypertensive patients
  • Home
  • /
  • Possibilities of antihypertensive therapy in correction of cognitive impairment in hypertensive patients
  1. Home /
  2. Archives /
  3. Vol. 10 No. 1 (2020) /
  4. Research Articles

Possibilities of antihypertensive therapy in correction of cognitive impairment in hypertensive patients

Authors

  • V. A. Skybchyk Danylo Halytsky Lviv Medical University
  • O. S. Pylypiv Chervonograd Central City Hospital

DOI:

https://doi.org/10.12775/JEHS.2020.10.01.017

Keywords

hypertension, cognitive impairment, antihypertensive therapy

Abstract

Data regarding possibilities of antihypertensive therapy to reduce a risk of the development of new cases of cognitive impairment are contradictory. So, the purpose of the study was to analyze the effect of antihypertensive therapy onto the dynamics of cognitive functions in hypertensive patients. We examined 90 patients with stage 1 and 2 hypertension, 2-3 degrees (middle age of patients was 49,66 ± 8,74 years). Clinical and anamnestic examination, laboratory and instrumental methods of examination were done to all patients. Neuropsychological tests, as GPCOG, MMSE, Schulte tables were used to study cognitive functions. Cognitive impairment were observed in 36 patients (40%). The combination of inhibitors of angiotensin-converting enzymes (іАCE) or angiotensin II receptor blockers (ARB) + calcium channel blocker (CCB) was used as antihypertensive therapy.  While using this therapy not only the decrease and normalization of blood pressure but also improvement of cognitive functions were noticed. Particularly, in 61,29% cases patients gained obviously more points in the retesting  MMSE(p=0,003) and GPCOG(p=0,01) and almost all patients (96,77%) needed less time to fulfill tasks by Schulte tables (p=0,0001). The total sum of points by MMSE scale increased by 3,66% (p=0,003), the total score by GPCOG scale increased by 22,24% (p=0,01), and in the control execution of Schulte test patients used less time by 14,39 % in comparison with initial results (p=0,0001).

References

Launer LJ. Midlife blood pressure and dementia: the Honolulu-Asia agingstudy / Launer LJ., Ross GW., Petrovitch H. [etal.] //NeurobiolAging. – 2000. – Vol. 21. – P. 49-55.

LeviMarpillat N. Antihypertensive classes, cognitive decline and incidence of dementia:a network meta-analysis / LeviMarpillat N., Macquin-Mavier I., Tropeano AI., Bachoud-Levi AC., Maison P. // J Hypertens. – 2013. – Vol. 31(6). – P. 1073–1082.

Hanon O. Effects of hypertension therapy based on eprosartanon systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study / Hanon O., Berrou JP., Negre-Pages L., Goch JH., Nadhazi Z., Petrella R. [etal.] // J Hypertens. – 2008. – Vol. 26(8). –Р. 1642–1650.

Fogari R. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension / Fogari R., Mugellini A., Zoppi A., Marasi G., Pasotti C., Poletti L., Rinaldi A., Preti P. // European Journal of Clinical Pharmacology. – 2004. – Vol.59. – Р. 863–868

Hajjar I. Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial / Hajjar I., Hart M., Chen Y.L., Mack W., Milberg W., Chui H.,Lipsitz L. // Arch. Intern. Med. – 2012. – Vol. 172(5). – P. 442-444.

McGuinness B. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia / McGuinness B., Todd S., Passmore P., Bullock R. // Cochrane Database of Systematic Reviews. – 2009. – Vol.4, doi.org/10.1002/14651858.CD004034.pub2

Watfa G, Rossignol P, Kearney-Schwartz A, Fay R, Bracard S,Felblinger J, etal. Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints. J Hypertens. 2010, № 28(12), Р. 2485–2493.

Primce M.J., Bird A.S., Blizard R.A. Is the cognitive function of alder patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s treatment trial of hypertension in older adults. BMJ 1996, № 312, P. 801–805.

Diz DI, Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension. 2008, № 52(1), Р. 37–43.

Gustafson DR, Melchior L, Eriksson E, Sundh V, Blennow K, Skoog I. The ACE insertion deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset. Neurobiol Aging.2010, № 31(6), Р. 910–916.

Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario LoresArnaizM, et al. Protective effect of the inhibition of the reninangiotensin system on aging. RegulPept. 2005, № 128(3), Р. 247–252.

Downloads

  • PDF

Published

2020-01-31

How to Cite

1.
SKYBCHYK, V. A. and PYLYPIV, O. S. Possibilities of antihypertensive therapy in correction of cognitive impairment in hypertensive patients. Journal of Education, Health and Sport. Online. 31 January 2020. Vol. 10, no. 1, pp. 150-157. [Accessed 23 September 2023]. DOI 10.12775/JEHS.2020.10.01.017.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 10 No. 1 (2020)

Section

Research Articles

License

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 266
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

hypertension, cognitive impairment, antihypertensive therapy
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Karmelitański Instytut Duchowości w Krakowie
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop